Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
37,096,947
-
Share change
-
+1,984,952
-
Total reported value
-
$439,965,000
-
Put/Call ratio
-
74%
-
Price per share
-
$11.86
-
Number of holders
-
61
-
Value change
-
-$3,133,551
-
Number of buys
-
40
-
Number of sells
-
30
Institutional Holders of TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR) as of Q2 2015
As of 30 Jun 2015,
TEKMIRA PHARMACEUTICALS CORP - COM NEW (TKMR) was held by
61 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
37,096,947 shares.
The largest 10 holders included
QVT Financial LP, Falcon Edge Capital LP, PRIMECAP MANAGEMENT CO/CA/, FRANKLIN RESOURCES INC, D. E. Shaw & Co., Inc., HealthCor Management, L.P., Blue Ridge Capital, L.L.C., MILLENNIUM MANAGEMENT LLC, RS INVESTMENT MANAGEMENT CO LLC, and BANK OF MONTREAL /CAN/.
This page lists
61
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.